In this study, we investigated whether salivary flotillin-1 could serve as a potential diagnostic biomarker for AD by analyzing flotillin-1 levels in the saliva and salivary glands of APP-KI mice and examining the underlying regulatory mechanisms. Here, APP is linked to Alzheimer disease.